{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T16:05:42Z","timestamp":1782057942990,"version":"3.54.5"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>Despite regularly being found in blood cultures, there are few studies of bloodstream infection (BSI) with <jats:italic>Citrobacter.<\/jats:italic> In this population-based study, the aim was to explore patient characteristics, outcome, and incidence in a publicly funded single payer setting.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Patients with growth of <jats:italic>Citrobacter<\/jats:italic> in blood culture were identified through the clinical microbiology laboratory in Lund, Sweden, for the year 2013\u20132023. This laboratory serves the whole Sk\u00e5ne region, with a population of 1.4\u00a0million. Medical records were retrospectively reviewed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>554 episodes of <jats:italic>Citrobacter<\/jats:italic> BSI were identified, with septic shock seen in 25 (4%) episodes and with 38 (7%) episodes resulting in intensive care. The 90-day mortality was 18% and the median age of the patients was 77 years. Resistance to cephalosporins was below 10%, and carbapenem resistance was not found in any isolates. A majority of episodes were healthcare associated or nosocomial, and almost half of BSI cases originated from the urinary tract. The association with the urinary tract was stronger for <jats:italic>C. koseri<\/jats:italic> BSI than for <jats:italic>C. freundii<\/jats:italic> complex BSI, which was more often polymicrobial and associated with abdominal surgery.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>\n              <jats:italic>Citrobacter<\/jats:italic> BSI was primarily found in elderly patients, either hospitalized or in close contact with healthcare in other ways. <jats:italic>C. koseri<\/jats:italic> BSI was to a greater extent associated with urinary tract focus compared to patients with BSI due to <jats:italic>C. freundii<\/jats:italic> complex, which was associated with abdominal source of infection and polymicrobial BSI.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12879-025-11972-6","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T11:38:02Z","timestamp":1760960282000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Citrobacter spp. bloodstream infection primarily affects the elderly either hospitalized or closely associated with health care \u2013 a population-based observational study with comparisons between C. koseri and the C. freundii complex"],"prefix":"10.1186","volume":"25","author":[{"given":"Torgny","family":"Sunnerhagen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiba","family":"Taie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Ohlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar","family":"Ljungquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,20]]},"reference":[{"issue":"8","key":"11972_CR1","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1128\/jcm.32.8.1850-1854.1994","volume":"32","author":"JM Janda","year":"1994","unstructured":"Janda JM, Abbott SL, Cheung WK, Hanson DF. Biochemical identification of citrobacteria in the clinical laboratory. J Clin Microbiol Aug. 1994;32(8):1850\u20134. https:\/\/doi.org\/10.1128\/jcm.32.8.1850-1854.1994.","journal-title":"J Clin Microbiol Aug"},{"issue":"4","key":"11972_CR2","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1099\/00207713-43-4-645","volume":"43","author":"DJ Brenner","year":"1993","unstructured":"Brenner DJ, Grimont PA, Steigerwalt AG, Fanning GR, Ageron E, Riddle CF. Classification of citrobacteria by DNA hybridization: designation of citrobacter Farmeri sp. nov., citrobacter youngae sp. nov., citrobacter Braakii sp. nov., citrobacter werkmanii sp. nov., citrobacter sedlakii sp. nov., and three unnamed citrobacter genomospecies. Int J Syst Bacteriol Oct. 1993;43(4):645\u201358. https:\/\/doi.org\/10.1099\/00207713-43-4-645.","journal-title":"Int J Syst Bacteriol Oct"},{"issue":"12","key":"11972_CR3","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1111\/j.1348-0421.1996.tb01160.x","volume":"40","author":"K Miki","year":"1996","unstructured":"Miki K, Tamura K, Sakazaki R, Kosako Y. Re-speciation of the original reference strains of serovars in the citrobacter freundii (Bethesda-Ballerup group) antigenic scheme of West and Edwards. Microbiol Immunol. 1996;40(12):915\u201321. https:\/\/doi.org\/10.1111\/j.1348-0421.1996.tb01160.x.","journal-title":"Microbiol Immunol"},{"issue":"3","key":"11972_CR4","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/clinids\/23.3.543","volume":"23","author":"CC Shih","year":"1996","unstructured":"Shih CC, Chen YC, Chang SC, Luh KT, Hsieh WC. Bacteremia due to citrobacter species: significance of primary intraabdominal infection. Clin Infect Dis Sep. 1996;23(3):543\u20139. https:\/\/doi.org\/10.1093\/clinids\/23.3.543.","journal-title":"Clin Infect Dis Sep"},{"issue":"4","key":"11972_CR5","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s15010-003-2176-8","volume":"31","author":"BN Kim","year":"2003","unstructured":"Kim BN, Woo JH, Ryu J, Kim YS. Resistance to extended-spectrum cephalosporins and mortality in patients with citrobacter freundii bacteremia. Infection Aug. 2003;31(4):202\u20137. https:\/\/doi.org\/10.1007\/s15010-003-2176-8.","journal-title":"Infection Aug"},{"issue":"1","key":"11972_CR6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/00006454-198701000-00013","volume":"6","author":"FC Lin","year":"1987","unstructured":"Lin FC, Devoe WF, Morrison C, et al. Outbreak of neonatal citrobacter diversus meningitis in a suburban hospital. Pediatr Infect Dis J Jan. 1987;6(1):50\u20135. https:\/\/doi.org\/10.1097\/00006454-198701000-00013.","journal-title":"Pediatr Infect Dis J Jan"},{"issue":"4","key":"11972_CR7","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jhin.2010.06.006","volume":"76","author":"CC Lai","year":"2010","unstructured":"Lai CC, Tan CK, Lin SH, et al. Bacteraemia caused by non-freundii, non-koseri citrobacter species in Taiwan. J Hosp Infect Dec. 2010;76(4):332\u20135. https:\/\/doi.org\/10.1016\/j.jhin.2010.06.006.","journal-title":"J Hosp Infect Dec"},{"key":"11972_CR8","doi-asserted-by":"publisher","first-page":"1276982","DOI":"10.3389\/frabi.2023.1276982","volume":"2","author":"I Jabeen","year":"2023","unstructured":"Jabeen I, Islam S, Hassan AKMI, Tasnim Z, Shuvo SR. A brief insight into. Front Antibiot. 2023;2:1276982. https:\/\/doi.org\/10.3389\/frabi.2023.1276982.","journal-title":"Front Antibiot"},{"key":"11972_CR9","doi-asserted-by":"publisher","unstructured":"Ljungquist O, Blomstergren A, Merkel A, Sunnerhagen T, Holm K, Torisson G. Incidence, aetiology and temporal trend of bloodstream infections in Southern Sweden from 2006 to 2019: a population-based study. Euro Surveill Mar. 2023;28(10). https:\/\/doi.org\/10.2807\/1560-7917.ES.2023.28.10.2200519.","DOI":"10.2807\/1560-7917.ES.2023.28.10.2200519"},{"issue":"10","key":"11972_CR10","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1080\/00365540310016376","volume":"35","author":"N Gupta","year":"2003","unstructured":"Gupta N, Yadav A, Choudhary U, Arora DR. Citrobacter bacteremia in a tertiary care hospital. Scand J Infect Dis. 2003;35(10):765\u20138. https:\/\/doi.org\/10.1080\/00365540310016376.","journal-title":"Scand J Infect Dis"},{"issue":"4","key":"11972_CR11","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jmii.2016.08.016","volume":"51","author":"LH Liu","year":"2018","unstructured":"Liu LH, Wang NY, Wu AY, Lin CC, Lee CM, Liu CP. Citrobacter freundii bacteremia: risk factors of mortality and prevalence of resistance genes. J Microbiol Immunol Infect Aug. 2018;51(4):565\u201372. https:\/\/doi.org\/10.1016\/j.jmii.2016.08.016.","journal-title":"J Microbiol Immunol Infect Aug"},{"issue":"1","key":"11972_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3947\/ic.2019.51.1.1","volume":"51","author":"R Lee","year":"2019","unstructured":"Lee R, Choi SM, Jo SJ, et al. Clinical characteristics and antimicrobial susceptibility trends in citrobacter bacteremia: an 11-Year Single-Center experience. Infect Chemother Mar. 2019;51(1):1\u20139. https:\/\/doi.org\/10.3947\/ic.2019.51.1.1.","journal-title":"Infect Chemother Mar"},{"issue":"5","key":"11972_CR13","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1093\/clinids\/2.5.746","volume":"2","author":"BA Lipsky","year":"1980","unstructured":"Lipsky BA, Hook EW 3rd, Smith AA, Plorde JJ. Citrobacter infections in humans: experience at the Seattle veterans administration medical center and a review of the literature. Rev Infect Dis Sep-Oct. 1980;2(5):746\u201360. https:\/\/doi.org\/10.1093\/clinids\/2.5.746.","journal-title":"Rev Infect Dis Sep-Oct"},{"issue":"1","key":"11972_CR14","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1186\/s12879-024-09575-8","volume":"2","author":"P Fonton","year":"2024","unstructured":"Fonton P, Hassoun-Kheir N, Harbarth S. Epidemiology of citrobacter spp. Infections among hospitalized patients: a systematic review and meta-analysis. BMC Infect Dis Jul. 2024;2(1):662. https:\/\/doi.org\/10.1186\/s12879-024-09575-8.","journal-title":"BMC Infect Dis Jul"},{"issue":"4","key":"11972_CR15","doi-asserted-by":"publisher","first-page":"313","DOI":"10.4103\/0974-7796.120297","volume":"5","author":"KP Ranjan","year":"2013","unstructured":"Ranjan KP, Ranjan N. Citrobacter: an emerging health care associated urinary pathogen. Urol Ann Oct. 2013;5(4):313\u20134.","journal-title":"Urol Ann Oct"},{"issue":"12","key":"11972_CR16","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.1093\/jac\/dkx325","volume":"1","author":"DM Arana","year":"2017","unstructured":"Arana DM, Ortega A, Gonzalez-Barbera E, et al. Carbapenem-resistant citrobacter spp. Isolated in Spain from 2013 to 2015 produced a variety of carbapenemases including VIM-1, OXA-48, KPC-2, NDM-1 and VIM-2. J Antimicrob Chemother Dec. 2017;1(12):3283\u20137. https:\/\/doi.org\/10.1093\/jac\/dkx325.","journal-title":"J Antimicrob Chemother Dec"},{"key":"11972_CR17","doi-asserted-by":"publisher","first-page":"744431","DOI":"10.3389\/fcimb.2021.744431","volume":"11","author":"Y Yao","year":"2021","unstructured":"Yao Y, Falgenhauer L, Falgenhauer J, et al. Carbapenem-Resistant citrobacter spp. As an emerging concern in the Hospital-Setting: results from a Genome-Based regional surveillance study. Front Cell Infect Microbiol. 2021;11:744431. https:\/\/doi.org\/10.3389\/fcimb.2021.744431.","journal-title":"Front Cell Infect Microbiol"},{"key":"11972_CR18","unstructured":"12.0 ECBTv. https:\/\/www.eucast.org\/clinical_breakpoints"},{"key":"11972_CR19","doi-asserted-by":"publisher","first-page":"100480","DOI":"10.1016\/j.ijregi.2024.100480","volume":"13","author":"O Karlbom","year":"2024","unstructured":"Karlbom O, Sunnerhagen T, Ljungquist O. Bloodstream infection affects the elderly in close contact with health care. IJID Reg Dec. 2024;13:100480. https:\/\/doi.org\/10.1016\/j.ijregi.2024.100480.","journal-title":"IJID Reg Dec"},{"key":"11972_CR20","unstructured":"National Early Warning Score (NEWS) Standardising the assessment of acute-illness severity in the NHS. 2012."},{"issue":"10","key":"11972_CR21","doi-asserted-by":"publisher","first-page":"791","DOI":"10.7326\/0003-4819-137-10-200211190-00007","volume":"19","author":"ND Friedman","year":"2002","unstructured":"Friedman ND, Kaye KS, Stout JE, et al. Health care\u2013associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med Nov. 2002;19(10):791\u20137. https:\/\/doi.org\/10.7326\/0003-4819-137-10-200211190-00007.","journal-title":"Ann Intern Med Nov"},{"key":"11972_CR22","doi-asserted-by":"publisher","unstructured":"Singer M, Deutschman CS, Seymour CW et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. Feb 23. 2016;315(8):801\u2009\u2013\u200910. https:\/\/doi.org\/10.1001\/jama.2016.0287.","DOI":"10.1001\/jama.2016.0287"},{"key":"11972_CR23","doi-asserted-by":"publisher","first-page":"737636","DOI":"10.3389\/fcimb.2021.737636","volume":"11","author":"L Liu","year":"2021","unstructured":"Liu L, Zhang L, Zhou H, et al. Antimicrobial resistance and molecular characterization of. Front Cell Infect Microbiol. 2021;11:737636. https:\/\/doi.org\/10.3389\/fcimb.2021.737636.","journal-title":"Front Cell Infect Microbiol"},{"key":"11972_CR24","doi-asserted-by":"publisher","unstructured":"Ljungquist O, Haldorsen B, Pontinen AK, et al. Nationwide, population-based observational study of the molecular epidemiology and temporal trend of carbapenemase-producing enterobacterales in Norway, 2015 to 2021. Euro Surveill Jul. 2023;28(27). https:\/\/doi.org\/10.2807\/1560-7917.ES.2023.28.27.2200774.","DOI":"10.2807\/1560-7917.ES.2023.28.27.2200774"},{"issue":"5","key":"11972_CR25","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1136\/bmjqs-2021-014243","volume":"31","author":"JK Valik","year":"2022","unstructured":"Valik JK, Hedberg P, Holmberg F, van der Werff SD, Naucler P. Impact of the COVID-19 pandemic on the incidence and mortality of hospital-onset bloodstream infection: a cohort study. BMJ Qual Saf May. 2022;31(5):379\u201382. https:\/\/doi.org\/10.1136\/bmjqs-2021-014243.","journal-title":"BMJ Qual Saf May"},{"issue":"1","key":"11972_CR26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jinf.2006.01.015","volume":"54","author":"S Mohanty","year":"2007","unstructured":"Mohanty S, Singhal R, Sood S, Dhawan B, Kapil A, Das BK. Citrobacter infections in a tertiary care hospital in Northern India. J Infect Jan. 2007;54(1):58\u201364. https:\/\/doi.org\/10.1016\/j.jinf.2006.01.015.","journal-title":"J Infect Jan"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11972-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11972-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11972-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T11:38:04Z","timestamp":1760960284000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11972-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,20]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11972"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11972-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,20]]},"assertion":[{"value":"3 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was granted ethical approval from the Swedish Ethical Review Authority (Dnr 2023-00921-01) and was conducted in compliance with the ethical principles adopted in the 2013 Declaration of Helsinki and the 2016 Declaration of Taipei. Due to the retrospective observational nature the need for informed consent to participate was waived by the ethical review authority.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1353"}}